66495-1-Ig

antibody from Proteintech Group

Targeting: BIRC5 API4, EPR-1, survivin

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66495-1-Ig

Provider

Proteintech Group

Product name

SURVIVIN antibody

Antibody type

Monoclonal

Description

KD/KO validated SURVIVIN antibody (Cat. #66495-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3B9H7

Vial size

20ul, 150ul

References

Submitted references

Onconase Induces Apoptosis in Dabrafenib-Resistant Melanoma Cell Lines Through Dysregulation of ROS Homeostasis, Antioxidant Protein Expression, and Mitochondrial Dynamics.

Passarini C, Cardile A, Zuanetti F, Zanrè V, Pacchiana R, Celesia A, Danzi F, Fiore A, Gotte G, Menegazzi M
International journal of molecular sciences 2026 Feb 7;27(4)

---

DNMT3b promotes proliferation and invasion by mediating HOPX DNA methylation in lung cancer.

Guan K, Zhao S, Zhang G, Wang Y, Song D, Ding Y
iScience 2026 Feb 20;29(2):114347

---

RNA-binding protein BICC1 promotes gastric cancer progression via the PRRX1-MAPK signaling axis.

Xing Y, Fan R, Jiang X, Zhu W, Jing F, Ma X, Wang Y, Jia Y
Functional & integrative genomics 2026 Feb 20;26(1):49

---

Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis.

Fang W, Chen C, Nie M, Liu Q, Huang T, Gao C, Liu Y, Zhou X, Wang X
Cell communication and signaling : CCS 2026 Feb 16;24(1)

---

Circular RNA circ_0050102 promotes colorectal cancer progression via modulation of the miR-3622a-3p/BIRC5 signaling pathway.

Wang B, Zhang B
Cell cycle (Georgetown, Tex.) 2026 Dec;25(1):1-19

---

Targeting intracellular cancer proteins with tumor-microenvironment-responsive bispecific nanobody-PROTACs for enhanced therapeutic efficacy.

Deng C, Ma J, Liu Y, Tong X, Wang L, Dong J, Shi P, Wang M, Zheng W, Ma X
MedComm 2025 Feb;6(2):e70068

---

Talaketides A-G, linear polyketides with prostate cancer cytotoxic activity from the mangrove sediment-derived fungus Talaromyces sp. SCSIO 41027.

Chen C, Wang X, Fang W, Liang J, Cai J, Yang D, Luo X, Gao C, Yi X, Liu Y, Zhou X
Chinese journal of natural medicines 2024 Nov;22(11):1047-1056

---

Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury.

Xu J, Zhang Z, Ren D, Liu L, Xing H, Wang D, Wu Y, Zhang Y, Chen Q, Wang T
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Mar;125:155346

---

Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens.

Sioud M, Juzeniene A, Sæbøe-Larssen S
Vaccines 2024 Jun 5;12(6)

---

Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.

Chen H, Zhang W, Shi J, Tang Y, Chen X, Li J, Yao X
Gene 2024 Jun 15;911:148333

---

The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells.

Galiger C, Zohora FT, Dorneburg C, Tews D, Debatin KM, Beltinger C
BMC cancer 2023 Nov 25;23(1):1148

---

Analysis of regulating activities of 5'-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo.

Wang X, Luo X, Gan X, Chen C, Yang Z, Wen J, Fang W, Huang H, Gao C, Zhou X, Feng X, Liu Y
Frontiers in pharmacology 2022;13:920554

---

Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene.

Zhang J, Tang Z, Guo X, Wang Y, Zhou Y, Cai W
Frontiers in oncology 2022;12:933646

---

Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy.

Hu F, Deng C, Zhou Y, Liu Y, Zhang T, Zhang P, Zhao Z, Miao H, Zheng W, Zhang W, Wang M, Ma X
Bioengineering & translational medicine 2022 May;7(2):e10290

---

m(6)A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis.

Yang J, Zhang M, Yang D, Ma Y, Tang Y, Xing M, Li L, Chen L, Jin Y, Ma C
Experimental & molecular medicine 2021 Nov;53(11):1723-1734

---

Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.

Gu J, Ji Z, Li D, Dong Q
Acta biochimica et biophysica Sinica 2019 Jan 1;51(1):59-67